The goal of Verax Research is to prepare and progress hemp-derived CBD to a quality and production level to be acceptable for use as an active ingredient in ethical medicines and ethical medical preparations. The first level of pharmaceuticals is OTC, while the following step-up is the development of an ethical drug for the amelioration of a specific disease.

For Verax Research, the ideal targets are rare diseases that are orphan indications and are aggressive. Drugs developed for these indications still are required to meet the “safe and effective” level but are provided more latitude during the development and clinical trial process.

Copyright 2019 | Verax Research, Inc.  All rights reserved